<DOC>
	<DOCNO>NCT00001295</DOCNO>
	<brief_summary>This protocol provide continue medical/surgical/radio-therapeutic care , treatment follow-up NCI patient currently enter active research protocol . No investigational treatment administer protocol .</brief_summary>
	<brief_title>Continuing Care Treatment Patients With Cancer/AIDS/Skin Disease</brief_title>
	<detailed_description>Background : It may interest CCR continue follow treat certain subject complete treatment participation research protocol . Objective : To provide continue treatment medical follow-up CCR subject complete treatment participation research protocol currently enter eligible another active research protocol . Eligibility : Subjects previously enrol receive treatment accord approve CCR research protocol . ( clinical trial ) It best interest subject CCR subject continue receive standard care follow-up NIH . Design : Medical/surgical/radiotherapeutic care , treatment follow-up provide CCR subject complete treatment participation research protocol currently enter active research protocol . No investigational treatment administer . This protocol use platform perform pilot study off-label us standard agent .</detailed_description>
	<criteria>INCLUSION CRITERIA : Subjects age previously enrol treat approved CCR research treatment protocol . It best interest subject CCR subject continue receive treatment followup NIH . The subject guardian sign inform consent agrees propose treatment regimen . EXCLUSION CRITERIA : Subjects previously treat CCR research treatment protocol . Subjects receive investigational therapy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 23, 2016</verification_date>
	<keyword>Follow-Up</keyword>
	<keyword>Treatment</keyword>
</DOC>